-
-
-
-
-
-
-
Ladenburg Thalmann Starts Inhibikase Therapeutics Inc (IKT) at Buy
-
-
-
-
-
-
-
Inhibikase Therapeutics (IKT) Misses Q2 EPS by 11c
-
-
-
-
-
-
-
Inhibikase Therapeutics (IKT) Misses Q3 EPS by 65c
-
-
-
-
443,900 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

